Companion Animal Welfare

Cat FIP Treatment Access Global Equity

FIP (feline infectious peritonitis) is now curable with antiviral drugs - global equity of access remains a significant welfare challenge for affected cats worldwide.

Key Facts

GS-441524 and molnupiravir achieve cure rates over 85% in FIP-affected cats
Treatment requires 12-week courses with daily injection or oral administration
Licensed drug costs exceed GBP3,000-5,000 per treatment course in many countries
Unlicensed generic versions from China are significantly cheaper but of variable quality
Many cats in lower-income countries cannot access treatment due to cost

Welfare Considerations

FIP has transformed from a universally fatal disease to a curable one - but only where treatment is accessible. The welfare gap between cats in wealthy countries with treatment access and cats elsewhere is both stark and largely preventable.

What You Can Do

Support organisations working to improve FIP treatment access globally
Advocate for veterinary pricing models that improve treatment accessibility
Donate to FIP welfare funds that subsidise treatment for owners who cannot afford full costs